Meeting: 2017 ASCO Annual Meeting Track: Melanoma/ Skin cancers Abstract number: 9505 Citation: J Clin Oncol 35, 2017 (suppl; abstr 9505) Authors: Georgina V. Long, Zeynep Eroglu, Jeffrey R. Infante, et. al. Background: D (BRAF inhibitor) + T (MEK inhibitor) combination therapy is associated with rapid clinical responses and has...
Pro zobrazení tohoto obsahu je třeba být přihlášen.